Access Statistics for Bruno Versaevel

Author contact details at EconPapers.

Working Paper	File Downloads				Abstract Views
Working Paper	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
Alertness, Leadership, and Nascent Market Dynamics	0	0	0	0	1	1	1	13
Alertness, Leadership, and Nascent Market Dynamics	0	0	0	0	3	3	5	16
Alertness, Leadership, and Nascent Market Dynamics	0	0	0	0	2	2	3	18
Alertness, Leadership, and Nascent Market Dynamics	0	0	0	0	1	4	6	19
Alertness, Leadership, and Nascent Market Dynamics	0	0	0	0	2	2	3	31
Alertness, Leadership, and Nascent Market Dynamics	0	0	0	0	4	5	7	16
Approche économique des accords de report d’entrée dans l’industrie pharmaceutique	0	0	0	0	1	1	2	2
Better than a compromise, a third way: Using patent pooling to accelerate access to vaccines and treatments against Covid-19	0	0	0	1	4	9	10	15
Better than a compromise, a third way: patent pool to accelerate access to vaccines and treatments against Covid-19	0	0	0	1	2	4	7	12
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?	0	0	0	0	3	5	7	11
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?	0	0	2	13	7	10	13	32
Caveat Preemptor: Coordination Failure and Success in a Duopoly Investment Game	0	0	0	0	1	2	3	39
Conflict and Cooperation on R&D Markets	0	0	0	90	3	4	6	290
Coordination and Cooperation in Investment Timing with Externalities?	0	0	0	17	5	8	11	112
Covid-19: Should intellectual property rights be challenged?	0	0	0	8	0	0	3	76
Dynamic competition and intellectual property rights in a model of product development	0	0	0	0	0	0	0	18
Dynamic competition and intellectual property rights in a model of product development	0	0	1	1	3	4	7	42
Dynamique des marchés et ajustement de la protection Intellectuelle	0	0	0	0	0	3	4	18
Dynamique des marchés et ajustement de la protection intellectuelle	0	0	0	0	0	0	1	9
Développements récents de l'approche économique des sanctions dans le cas des cartels	0	0	0	0	1	1	3	10
Développements récents de l'approche économique des sanctions dans le cas des cartels	0	0	0	0	1	2	3	20
Développements récents de l'approche économique des sanctions dans le cas des cartels	0	0	0	0	1	4	4	32
From Private to Public Common Agency	0	0	0	0	3	7	9	49
From private to public common agency	0	0	0	0	3	5	8	15
Horizontal R&D Cooperation and Spillovers: Evidence from France	0	0	0	0	1	2	3	10
Implications des licences FRAND pour la concurrence: un regard économique	0	0	0	0	1	2	4	12
Implications des licences FRAND pour la concurrence: un regard économique	0	0	0	0	1	1	3	19
Innovation and Imitation Incentives in Dynamic Duopoly	0	0	0	0	3	6	8	39
Innovation and Imitation Incentives in Dynamic Duopoly	0	0	0	0	2	8	9	40
Innovation and imitation incentives in dynamic duopoly	0	0	0	49	3	5	8	101
Investment Timing and Vertical Relationships	0	0	0	37	3	6	7	96
Investment timing and vertical relationships	0	0	0	0	2	2	4	12
Market Share, R&D Cooperation, and EU Competition Policy	0	0	2	3	4	8	11	36
Market shares, R&D agreements, and the EU block exemption	0	0	0	0	4	5	8	21
Market shares, R&D agreements, and the EU block exemption	0	0	0	0	2	2	5	36
Mise en oeuvre de la collusion et détection: approches actives et passives	0	0	0	0	1	2	2	5
Mise en oeuvre de la collusion et détection: approches actives et passives	0	0	0	0	1	1	2	16
On the Optimal Timing of Innovation and Imitation	0	0	0	0	1	3	3	19
On the Timing of Vertical Relationships	0	0	0	45	4	6	8	88
On the tacit collusion equilibria of a dynamic duopoly investment game	0	0	0	0	0	0	1	11
On the timing of innovation and imitation	0	0	0	28	3	6	7	49
On the timing of innovation and imitation in dynamic duopoly	0	0	0	0	1	2	2	12
On the timing of vertical relationships	0	0	0	36	1	2	7	77
One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry	0	0	0	28	1	8	10	68
One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry	0	0	0	0	7	8	9	38
One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry	0	0	0	0	1	3	4	15
One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry	0	0	0	0	4	7	8	21
Optimal Collusion with Limited Liability	0	0	0	0	4	6	8	41
Optimal Collusion with Limited Liability and Policy Implications	0	0	0	0	2	3	3	25
Optimal Collusion with Limited Liability and Policy Implications	0	0	0	52	2	7	10	128
Optimal collusion with limited liability	0	0	0	40	3	6	8	95
Patent Pools and Dynamic R&D Incentives	0	0	0	0	2	5	6	28
Patent Pools and R&D Dynamics	0	0	0	0	3	4	5	29
Patent pools and dynamic R&D incentives	0	0	0	0	3	3	4	46
Pool patents to get COVID vaccines and drugs to all	0	0	0	7	1	1	1	34
Quel rôle pour la part de marché quand le droit de la concurrence porte son regard sur la coopération et l'innovation	0	0	0	0	0	1	3	14
Quel rôle pour un critère de part de marché dans la réglementation de la coopération en recherche et développement ?	0	0	0	0	1	1	4	10
Quelles spécificités des accords de distribution en ligne ?	0	0	0	0	1	1	3	10
R&D Delegation in a Duopoly with Spillovers	0	0	0	0	5	9	9	21
R&D Delegation in a Duopoly with Spillovers	0	0	0	0	4	7	8	9
Tacit Collusion in Investment Timing	0	0	0	0	0	0	0	16
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline	0	0	0	47	5	7	9	258
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline	0	0	0	47	4	6	10	253
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline	0	0	0	32	2	3	5	136
Timing Vertical Relationships	0	0	0	0	1	1	2	23
Timing Vertical Relationships	0	0	0	0	1	3	5	28
Timing Vertical Relationships	0	0	0	53	3	6	6	78
Timing Vertical Relationships	0	0	0	0	4	4	5	20
Timing Vertical Relationships	0	0	0	0	2	3	3	28
Timing Vertical Relationships	0	0	0	0	3	3	3	23
When should a winner take all, or pay some? Innovation and imitation incentives in a dynamic duopoly	0	0	0	77	3	6	10	63
Total Working Papers	0	0	5	712	161	277	389	3,172

3 registered items for which data could not be found

Journal Article	File Downloads				Abstract Views
Journal Article	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
Alertness, Leadership, and Nascent Market Dynamics	0	0	0	2	3	6	14	50
Caveat preemptor: Coordination failure and success in a duopoly investment game	0	0	0	11	3	4	10	114
Co-ordination costs and vertical integration in production franchise networks: a common agency model	0	0	0	46	2	3	4	140
Dynamic competition and intellectual property rights in a model of product development	0	0	0	7	2	4	11	87
From private to public common agency	0	0	1	29	4	5	6	123
Horizontal R and D cooperation and spillovers: evidence from France	0	0	0	5	3	5	6	47
Investment timing and vertical relationships	0	1	1	17	2	5	8	53
La spéculation sur le marché des actions: un phénomène monétaire ?	0	0	0	1	0	0	1	19
Market shares, R&D agreements, and the EU block exemption	0	0	0	11	7	7	7	88
Mieux qu’un compromis, une troisième voie: le panier de brevets pour accélérer l’accès aux vaccins et traitements contre la COVID-19	0	0	0	5	1	3	6	16
On the tacit collusion equilibria of a dynamic duopoly investment game	0	0	0	12	2	2	4	80
One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry	0	0	0	2	4	6	13	54
Optimal collusion with limited liability	0	0	0	9	4	8	10	74
Patent pools and dynamic R&D incentives	0	0	0	27	8	11	15	128
Pool patents to get COVID vaccines and drugs to all	0	0	0	3	3	5	6	16
R&D Delegation in a Duopoly with Spillovers	0	0	1	26	2	3	6	113
Total Journal Articles	0	1	3	213	50	77	127	1,202

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Authors with no registered papers

LogEc provides access and usage statistics for services based on the RePEc data set.

LogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Statistics updated 2026-02-12